SE9301172L - - Google Patents
Info
- Publication number
- SE9301172L SE9301172L SE9301172A SE9301172A SE9301172L SE 9301172 L SE9301172 L SE 9301172L SE 9301172 A SE9301172 A SE 9301172A SE 9301172 A SE9301172 A SE 9301172A SE 9301172 L SE9301172 L SE 9301172L
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3634825 | 1986-10-13 | ||
DE3634826 | 1986-10-13 | ||
DE3634797 | 1986-10-13 | ||
DE3712626 | 1987-04-14 | ||
CH315387 | 1987-08-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9301172L true SE9301172L (pl) | 1900-01-01 |
SE9301172D0 SE9301172D0 (sv) | 1993-04-07 |
SE518630C2 SE518630C2 (sv) | 2002-11-05 |
Family
ID=27509117
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8703938A SE8703938L (sv) | 1986-10-13 | 1987-10-12 | Peptidderivat |
SE9301172A SE518630C2 (sv) | 1986-10-13 | 1993-04-07 | Förfarande för framställning av en peptidalkohol |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8703938A SE8703938L (sv) | 1986-10-13 | 1987-10-12 | Peptidderivat |
Country Status (23)
Country | Link |
---|---|
US (1) | US5656721A (pl) |
JP (2) | JPH0645639B2 (pl) |
KR (1) | KR960016861B1 (pl) |
AU (2) | AU617986B2 (pl) |
BE (1) | BE1003752A4 (pl) |
CA (1) | CA1340985C (pl) |
CH (2) | CH682632A5 (pl) |
DE (1) | DE3790635T1 (pl) |
DK (1) | DK174337B1 (pl) |
ES (1) | ES2007418A6 (pl) |
FI (1) | FI874495A (pl) |
FR (1) | FR2609991A1 (pl) |
GB (2) | GB2199829B (pl) |
GR (1) | GR871567B (pl) |
HU (3) | HU206890B (pl) |
IE (1) | IE912442A1 (pl) |
LU (1) | LU87014A1 (pl) |
NL (1) | NL194729C (pl) |
NZ (1) | NZ222133A (pl) |
PL (1) | PL157156B1 (pl) |
PT (1) | PT85904B (pl) |
SE (2) | SE8703938L (pl) |
WO (1) | WO1988002756A2 (pl) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL194729C (nl) * | 1986-10-13 | 2003-01-07 | Novartis Ag | Werkwijze voor de bereiding van peptidealcoholen via vaste fase. |
DE3845000C2 (de) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
AU632468B2 (en) * | 1988-02-01 | 1993-01-07 | Upjohn Company, The | Renin inhibiting peptides with polar end groups |
DK163689A (da) * | 1988-04-08 | 1989-10-30 | Sandoz Ag | Peptidderivater |
DE3910667A1 (de) * | 1988-04-11 | 1989-10-19 | Sandoz Ag | Peptidderivate |
GB8813339D0 (en) * | 1988-06-06 | 1988-07-13 | Sandoz Ltd | Improvements in/relating to organic compounds |
FR2638968B1 (fr) * | 1988-11-11 | 1994-10-07 | Sandoz Sa | Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5753627A (en) * | 1988-12-05 | 1998-05-19 | Novartis Ag | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
IT1229514B (it) * | 1989-01-30 | 1991-09-03 | Farmhispania S A A Montme | Glicoconiugati anfifilici sintetici per impiego neurologico. |
DK111489D0 (da) * | 1989-03-08 | 1989-03-08 | Novo Nordisk As | Peptider |
DE4206858A1 (de) * | 1992-03-05 | 1993-09-09 | Behringwerke Ag | Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
TW263437B (pl) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US5710244A (en) * | 1992-12-31 | 1998-01-20 | Labroo; Virender M. | Derivatized calcitonins |
US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
ATE284413T1 (de) * | 1993-08-09 | 2004-12-15 | Sod Conseils Rech Applic | Therapeutische peptid derivate |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
JP3896430B2 (ja) * | 1996-07-15 | 2007-03-22 | アークレイ株式会社 | 糖化アミノ化合物の製造方法 |
IL119029A0 (en) * | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
PT981363E (pt) | 1997-05-13 | 2003-12-31 | Conseils De Rec Appl Scient S | Somatostatina e agonistas da somatostatina para reduzir o peso corporal |
WO1998051330A1 (en) | 1997-05-13 | 1998-11-19 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) | Method and compositions for treating hyperlipidemia and other conditions |
WO1999040928A1 (en) * | 1998-02-13 | 1999-08-19 | Amylin Pharmaceuticals, Inc. | Novel mixed amylin activity compounds |
US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
US20050037490A1 (en) * | 1999-10-29 | 2005-02-17 | Lawrence Rosenberg | Medium for preparing dedifferentiated cells |
AU2002254691B8 (en) * | 2001-04-23 | 2008-02-14 | Mallinckrodt Inc. | Tc and Re labeler radioactive glycosylated octreotide derivatives |
EP2062914B1 (en) | 2001-06-08 | 2014-05-07 | Ipsen Pharma | Somatostatin-dopamine chimeric analogs |
ATE346084T1 (de) * | 2002-02-27 | 2006-12-15 | Ferring Bv | Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
DE602006012513D1 (de) | 2005-08-26 | 2010-04-08 | Healthpartners Res Foundation | Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin |
SI1787658T1 (sl) | 2005-11-10 | 2012-07-31 | Chemi Spa | Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona |
WO2008011168A2 (en) * | 2006-07-21 | 2008-01-24 | Amgen Inc. | Glycosylated peptide antagonists of the bradykinin b1 receptor |
JP5649825B2 (ja) | 2007-01-31 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | 安定化させたp53ペプチドおよびその使用法 |
JP5631201B2 (ja) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
AU2008303584C1 (en) | 2007-09-25 | 2013-10-10 | Glycom A/S | Glycoproteins and glycosylated cells and a method for the preparation of the same |
JP5660898B2 (ja) * | 2007-11-09 | 2015-01-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 経口投与用の抗炎症性キナ酸誘導体 |
JP5728380B2 (ja) | 2008-06-12 | 2015-06-03 | シンタクシン リミテッドSyntaxin Limited | 神経内分泌疾患の抑制 |
EP3473643A1 (en) | 2008-06-12 | 2019-04-24 | Ipsen Bioinnovation Limited | Fusion proteins for use in the treatemnt of cancer |
WO2010089757A2 (en) * | 2008-11-07 | 2010-08-12 | Usv Limited | An improved process for synthesis of cyclic octapeptide |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
RU2016111360A (ru) | 2010-08-13 | 2018-11-27 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
SG10201601327RA (en) | 2011-09-04 | 2016-03-30 | Glytech Inc | Glycosylated polypeptide and drug composition containing said polypeptide |
WO2013032011A1 (ja) | 2011-09-04 | 2013-03-07 | 株式会社糖鎖工学研究所 | 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物 |
KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス,インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
CN107216380A (zh) | 2012-02-15 | 2017-09-29 | 爱勒让治疗公司 | 拟肽大环化合物 |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
AU2014280847B2 (en) | 2013-06-13 | 2019-07-04 | Antisense Therapeutics Ltd | Combination therapy |
CA2961258A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
AU2016205225A1 (en) | 2015-01-07 | 2017-08-17 | Trigemina, Inc. | Magnesium-containing oxytocin formulations and methods of use |
WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
WO2019104214A1 (en) | 2017-11-22 | 2019-05-31 | Dauntless 2, Inc. | Membrane emulsification device for microsphere creation |
US20200281857A1 (en) | 2017-11-22 | 2020-09-10 | Dauntless 1, Inc. | Therapeutic compound formulations |
WO2020005842A1 (en) | 2018-06-25 | 2020-01-02 | Dauntless 2, Inc. | Membrane emulsification device with impeller for microsphere creation |
JP2022529774A (ja) | 2019-04-16 | 2022-06-24 | バッヘン・ホールディング・アクチエンゲゼルシャフト | ジスルフィド結合ペプチドの製造 |
WO2022087385A1 (en) * | 2020-10-22 | 2022-04-28 | The Trustees Of Indiana University | Molecular designs of glucose-responsive and glucose-cleavable insulin analogues |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254023A (en) * | 1979-10-16 | 1981-03-03 | Pennwalt Corporation | Synthesis of peptide alcohols by the solid phase method |
US4280953A (en) * | 1979-11-08 | 1981-07-28 | The Salk Institute For Biological Studies | Glycosylated analogs of somatostatin |
ATE2512T1 (de) * | 1979-11-27 | 1983-03-15 | Sandoz Ag | Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung. |
FR2522967B1 (fr) * | 1982-03-15 | 1986-03-07 | Anvar | Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant |
US4483792A (en) * | 1982-11-17 | 1984-11-20 | Kim Wan S | Glycosylated insulin derivatives |
US4444683A (en) * | 1982-11-17 | 1984-04-24 | University Of Utah | Glycosylated insulin derivatives |
FR2546163B1 (fr) * | 1983-05-16 | 1987-10-09 | Centre Nat Rech Scient | Nouveaux derives acyles hydrosolubles de peptides ou d'amino-acides, leur preparation et leur application |
FR2548673B1 (fr) * | 1983-07-05 | 1985-10-04 | Essilor Int | Polymeres supports de produits actifs relargables et leur procede de preparation |
LU85269A1 (fr) * | 1984-03-26 | 1985-10-14 | Techland S A | Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux |
US4564998A (en) * | 1984-10-19 | 1986-01-21 | Westinghouse Electric Corp. | Coil winding methods and apparatus |
DE3439610A1 (de) * | 1984-10-30 | 1986-04-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin |
FI860708A (fi) * | 1985-02-20 | 1986-08-21 | Ciba Geigy Ag | Acylerade hexosderivat och foerfarande foer deras framstaellning. |
JPS61264260A (ja) * | 1985-05-17 | 1986-11-22 | Rikagaku Kenkyusho | アルデヒド化多孔性高分子材料によるタンパク質の除去方法 |
AU597909B2 (en) * | 1985-10-09 | 1990-06-14 | Procter & Gamble Company, The | Granular detergent compositions having improved solubility |
SE8506094D0 (sv) * | 1985-12-20 | 1985-12-20 | Astra Laekemedel Ab | New antibacterial agents and intermediates therefor |
JPS63165411A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製法 |
JPS63165410A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製造方法 |
NL194729C (nl) * | 1986-10-13 | 2003-01-07 | Novartis Ag | Werkwijze voor de bereiding van peptidealcoholen via vaste fase. |
US4859736A (en) * | 1987-03-30 | 1989-08-22 | Ciba-Geigy Corporation | Synthetic polystyrene resin and its use in solid phase peptide synthesis |
CH679045A5 (pl) * | 1987-06-29 | 1991-12-13 | Sandoz Ag |
-
1987
- 1987-10-01 NL NL8702345A patent/NL194729C/nl not_active IP Right Cessation
- 1987-10-01 HU HU874432A patent/HU206890B/hu not_active IP Right Cessation
- 1987-10-01 HU HU906341A patent/HU906341D0/hu unknown
- 1987-10-01 HU HU906340A patent/HU906340D0/hu unknown
- 1987-10-07 LU LU87014A patent/LU87014A1/fr unknown
- 1987-10-07 FR FR8713949A patent/FR2609991A1/fr active Granted
- 1987-10-09 BE BE8701187A patent/BE1003752A4/fr not_active IP Right Cessation
- 1987-10-09 GB GB8723737A patent/GB2199829B/en not_active Expired - Lifetime
- 1987-10-12 JP JP62257047A patent/JPH0645639B2/ja not_active Expired - Lifetime
- 1987-10-12 FI FI874495A patent/FI874495A/fi not_active Application Discontinuation
- 1987-10-12 DK DK198705327A patent/DK174337B1/da not_active IP Right Cessation
- 1987-10-12 KR KR1019870011265A patent/KR960016861B1/ko not_active IP Right Cessation
- 1987-10-12 CH CH1353/89A patent/CH682632A5/de not_active IP Right Cessation
- 1987-10-12 NZ NZ222133A patent/NZ222133A/xx unknown
- 1987-10-12 PT PT85904A patent/PT85904B/pt unknown
- 1987-10-12 CH CH3804/90A patent/CH680512A5/de not_active IP Right Cessation
- 1987-10-12 PL PL1987268173A patent/PL157156B1/pl unknown
- 1987-10-12 GR GR871567A patent/GR871567B/el unknown
- 1987-10-12 DE DE19873790635 patent/DE3790635T1/de active Pending
- 1987-10-12 AU AU79564/87A patent/AU617986B2/en not_active Ceased
- 1987-10-12 SE SE8703938A patent/SE8703938L/ not_active Application Discontinuation
- 1987-10-12 WO PCT/EP1987/000593 patent/WO1988002756A2/en active Application Filing
- 1987-10-13 CA CA000549140A patent/CA1340985C/en not_active Expired - Lifetime
- 1987-10-13 ES ES8702913A patent/ES2007418A6/es not_active Expired
-
1988
- 1988-01-12 GB GB8800537A patent/GB2199831B/en not_active Expired - Lifetime
-
1990
- 1990-06-04 JP JP2147161A patent/JP2744910B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-03 AU AU80150/91A patent/AU634664B2/en not_active Expired
- 1991-07-12 IE IE244291A patent/IE912442A1/en unknown
-
1993
- 1993-04-07 SE SE9301172A patent/SE518630C2/sv unknown
-
1994
- 1994-07-07 US US08/272,704 patent/US5656721A/en not_active Expired - Lifetime